Clinical Trials Market Size, CAGR and Country-Specific Trade Data
According to Rohan Patil, who specializes in clinical research, pharmaceutical markets, and healthcare industry analysis, with 5+ years of experience in market research and industry analysis, my research shows that the global clinical trials market is on track to grow from USD 98.91 billion in 2026 to USD 174.18 billion by 2035 at a 5.7% CAGR, driven by personalized medicine, decentralized trials, and rising R&D investments. I found that Phase 3, interventional studies, and oncology continue to lead market demand, while North America remains the largest regional market and Asia Pacific records the fastest growth. My analysis also highlights the competitive presence of Parexel, IQVIA, Charles River Laboratory, Omnicare, Kendle, Chiltern, and Pharmaceutical Product Development, LLC, as these companies continue to shape innovation and global clinical research expansion.
Last Updated : 27 February 2026
Category: Healthcare Services
Insight Code: 5018
Format: PDF / PPT / Excel